Closely held Aqua Medical is advancing therapy for gastrointestinal (GI) and metabolic diseases—including Type 2 diabetes—using its disruptive, transoral, outpatient vapor-based endoscopic ablation platform.

Closely held Experity Health is shaping the future of healthcare by embedding AI into urgent care hubs across the U.S. to improve patient access, speed clinical visits, and elevate care quality.

Tyler B. Evans, MD, MS, MPH, is a leading voice in global health equity, infectious disease, and humanitarian medicine. As co-founder, CEO, and chief medical officer of Wellness Equity Alliance (WEA), Dr. Evans has...

Consultancy Cell One Partners is helping innovators translate scientific ambition into viable commercial solutions as the cell and gene therapy industry pushes toward its next era of breakthroughs. Through deep domain...

Closely held Micoy Therapeutics is advancing novel, first-in-class therapeutics to target harmful autoantibodies that induce immunodeficiency by inhibiting immune signaling molecules—type I interferons—which are...

Closely held Likarda is advancing a novel modality for delivering cellular therapies—a proprietary, customizable hydrogel delivery system engineered for controlled release, immune protection, and high cell viability.

Closely held Solu Therapeutics is pairing heterobifunctional small molecules with monoclonal antibodies to develop therapeutic agents that eliminate disease-driving cells in cancer, immunology, and other therapeutic...

Closely held Nimbus Therapeutics is designing and developing precisely tailored small molecule medicines for challenging targets by leveraging a unique strategy that combines computational chemistry technologies with...

Closely held EsoBiotec is transforming cell therapy by engineering immune cells directly within a patient’s body, enabling the immune system to attack disease—potentially delivering cell therapy to patients in minutes...

Closely held Dotmatics is transforming the therapeutic research and development landscape with Luma, a groundbreaking solution in multimodal data management with the potential to address long-standing scientific...

Closely held JVP Labs is developing the only non-invasive, real-time cardiac filling pressure monitoring solution for managing congestive heart failure (CHF) patients—for both in the hospital and at home.